NCT06153095: A trial that was reported late by ImmPACT Bio
This trial was previously reported as an Applicable Clinical Trial, but is no longer.
Full data
| Full entry on ClinicalTrials.gov | NCT06153095 |
|---|---|
| Title | A Phase 1/2 Open-label Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Efficacy of IMPT-514 in Participants With Active, Refractory Lupus Nephritis and Systemic Lupus Erythematosus |
| Results Status | no-longer-act |
| ACT or pACT? | This is what FDAAA officially calls an "Applicable Clinical Trial" |
| Start date | Feb. 15, 2024 |
| Completion date | Feb. 28, 2027 |
| Required reporting date | Feb. 28, 2028, midnight |
| Actual reporting date | None |
| Date last checked at ClinicalTrials.gov | Jan. 27, 2025 |
| Days late | None |